Valuation Joinn Laboratories(China)Co.,Ltd.
Stocks
603127
CNE100002W27
Biotechnology & Medical Research
|
End-of-day quote
Shanghai S.E.
2026-10-23
|
5-day change | 1st Jan Change | ||
| 45.35 CNY | -0.44% |
|
-6.90% | +29.53% |
| 09-24 | Joinn Laboratories' Unit Subscribes to Asset Management Products for 540 Million Yuan | MT |
| 08-28 | Joinn Laboratories' H1 Attributable Profit Surges; Revenue Up | MT |
Company Valuation: Joinn Laboratories(China)Co.,Ltd.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 40,246 | 29,328 | 16,313 | 11,374 | 23,924 | 30,517 | - | - |
| Change | - | -27.13% | -44.38% | -30.28% | 110.35% | 27.56% | - | - |
| Enterprise Value (EV) 1 | 36,161 | 26,442 | 13,478 | 10,430 | 23,032 | 28,748 | 28,483 | 28,125 |
| Change | - | -26.88% | -49.03% | -22.61% | 120.83% | 24.82% | -0.92% | -1.26% |
| P/E | 76.4x | 29.2x | 44.7x | 166x | 87.5x | 38.2x | 57.8x | 41.5x |
| PBR | 6.16x | 3.82x | 2.15x | 1.54x | 3.15x | 3.79x | 3.65x | 3.43x |
| PEG | - | 0.3x | -0.7x | -2x | 0x | 0x | -1.7x | 1.1x |
| Capitalization / Revenue | 26.5x | 12.9x | 6.86x | 5.64x | 14.4x | 16.4x | 14x | 11.1x |
| EV / Revenue | 23.8x | 11.7x | 5.67x | 5.17x | 13.9x | 15.5x | 13x | 10.2x |
| EV / EBITDA | 50x | 19.8x | 21.5x | 48.8x | 46x | 101x | 48.7x | 35.7x |
| EV / EBIT | 56.2x | 21.6x | 26.6x | 152x | 68x | 14,235x | 161x | 60.8x |
| EV / FCF | 80.6x | 38x | 31.3x | 153x | 76.5x | 62.6x | 192x | 132x |
| FCF Yield | 1.24% | 2.63% | 3.19% | 0.65% | 1.31% | 1.6% | 0.52% | 0.76% |
| Dividend per Share 2 | 0.1837 | 0.2857 | 0.16 | 0.03 | 0.12 | 0.28 | 0.155 | 0.21 |
| Rate of return | 0.31% | 0.68% | 0.67% | 0.18% | 0.34% | 0.62% | 0.34% | 0.46% |
| EPS 2 | 0.7704 | 1.429 | 0.53 | 0.1 | 0.4 | 1.189 | 0.785 | 1.092 |
| Distribution rate | 23.8% | 20% | 30.2% | 30% | 30% | 23.6% | 19.7% | 19.2% |
| Net sales 1 | 1,517 | 2,268 | 2,376 | 2,018 | 1,658 | 1,858 | 2,186 | 2,754 |
| EBITDA 1 | 723.1 | 1,333 | 626.1 | 213.9 | 500.7 | 283.3 | 585.1 | 787.8 |
| EBIT 1 | 643 | 1,226 | 507.1 | 68.81 | 338.9 | 2.02 | 176.9 | 462.6 |
| Net income 1 | 557 | 1,074 | 397 | 74.08 | 297.8 | 787.9 | 373.6 | 795.6 |
| Net Debt 1 | -4,085 | -2,886 | -2,835 | -943.6 | -891.7 | -1,770 | -2,034 | -2,392 |
| Reference price 2 | 58.89 | 41.72 | 23.71 | 16.63 | 35.01 | 45.35 | 45.35 | 45.35 |
| Nbr of stocks (in thousands) | 747,243 | 749,950 | 746,974 | 733,989 | 733,375 | 733,375 | - | - |
| Announcement Date | 2/24/22 | 3/30/23 | 3/28/24 | 3/28/25 | 3/30/26 | - | - | - |
1CNY in Million2CNY
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 38.15x | 15.47x | 101.46x | 0.62% | 4.58B | |
| 18.83x | 6.63x | 13.18x | 1.58% | 64.69B | |
| 30.16x | 8x | 26.2x | 0.05% | 54.78B | |
| 36.79x | 6.53x | 19.51x | 0.88% | 53.49B | |
| 35.59x | 3.45x | 14.87x | -.--% | 45.98B | |
| 49.71x | 5.74x | 31.52x | -.--% | 42.94B | |
| -19.41x | 187.75x | -20.66x | -.--% | 40.08B | |
| 28.93x | 8.21x | 21.27x | 0.37% | 33.52B | |
| 27.67x | 5.83x | 15.12x | -.--% | 23.97B | |
| 32.66x | 5.97x | 20.09x | -.--% | 23.67B | |
| Average | 27.91x | 25.36x | 24.26x | 0.35% | 38.77B | |
| Weighted average by Cap. | 26.86x | 25.21x | 16.91x | 0.43% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- 603127 Stock
- Valuation Joinn Laboratories(China)Co.,Ltd.
Select your edition
All financial news and data tailored to specific country editions
